Kurkinen K, Karkkainen O, Lehto S, Luoma I, Kraav S, Kivimaki P
Transl Psychiatry. 2024; 14(1):466.
PMID: 39511135
PMC: 11543670.
DOI: 10.1038/s41398-024-03163-9.
Yue W, Huang H, Duan J
Med Rev (2021). 2023; 2(4):385-416.
PMID: 37724326
PMC: 10388817.
DOI: 10.1515/mr-2022-0009.
Romer T, Jeppesen R, Christensen R, Benros M
Mol Psychiatry. 2023; 28(6):2277-2290.
PMID: 37169812
DOI: 10.1038/s41380-023-02059-2.
Karahalil B, Elkama A, Ak M, Nemutlu E
Toxicol Res (Camb). 2022; 11(3):547-556.
PMID: 35782649
PMC: 9244978.
DOI: 10.1093/toxres/tfac034.
Liu Y, Ouyang P, Zheng Y, Mi L, Zhao J, Ning Y
Front Cell Dev Biol. 2021; 9:664535.
PMID: 34746116
PMC: 8567014.
DOI: 10.3389/fcell.2021.664535.
A New Look on an Old Issue: Comprehensive Review of Neurotransmitter Studies in Cerebrospinal Fluid of Patients with Schizophrenia and Antipsychotic Effect on Monoamine's Metabolism.
Gasnier M, Ellul P, Plaze M, Abdel Ahad P
Clin Psychopharmacol Neurosci. 2021; 19(3):395-410.
PMID: 34294610
PMC: 8316661.
DOI: 10.9758/cpn.2021.19.3.395.
Assessing causal links between metabolic traits, inflammation and schizophrenia: a univariable and multivariable, bidirectional Mendelian-randomization study.
Lin B, Alkema A, Peters T, Zinkstok J, Libuda L, Hebebrand J
Int J Epidemiol. 2019; 48(5):1505-1514.
PMID: 31504541
PMC: 7070229.
DOI: 10.1093/ije/dyz176.
Blood Levels of Monoamine Precursors and Smoking in Patients with Schizophrenia.
Mathai A, Kanwar J, Okusaga O, Fuchs D, Lowry C, Peng X
Front Public Health. 2016; 4:182.
PMID: 27626030
PMC: 5003942.
DOI: 10.3389/fpubh.2016.00182.
Taurine and Epidermal Growth Factor Belong to the Signature of First-Episode Psychosis.
Koido K, Innos J, Haring L, Zilmer M, Ottas A, Vasar E
Front Neurosci. 2016; 10:331.
PMID: 27471446
PMC: 4945631.
DOI: 10.3389/fnins.2016.00331.
Metabolomic Profiling of Post-Mortem Brain Reveals Changes in Amino Acid and Glucose Metabolism in Mental Illness Compared with Controls.
Zhang R, Zhang T, Ali A, Al Washih M, Pickard B, Watson D
Comput Struct Biotechnol J. 2016; 14:106-16.
PMID: 27076878
PMC: 4813093.
DOI: 10.1016/j.csbj.2016.02.003.
Polymorphisms in genes implicated in dopamine, serotonin and noradrenalin metabolism suggest association with cerebrospinal fluid monoamine metabolite concentrations in psychosis.
Andreou D, Soderman E, Axelsson T, Sedvall G, Terenius L, Agartz I
Behav Brain Funct. 2014; 10:26.
PMID: 25073638
PMC: 4123495.
DOI: 10.1186/1744-9081-10-26.
Systematic analysis of transcription-level effects of neurodegenerative diseases on human brain metabolism by a newly reconstructed brain-specific metabolic network.
Sertbas M, Ulgen K, Cakir T
FEBS Open Bio. 2014; 4:542-53.
PMID: 25061554
PMC: 4104795.
DOI: 10.1016/j.fob.2014.05.006.
Elevated levels of plasma phenylalanine in schizophrenia: a guanosine triphosphate cyclohydrolase-1 metabolic pathway abnormality?.
Okusaga O, Muravitskaja O, Fuchs D, Ashraf A, Hinman S, Giegling I
PLoS One. 2014; 9(1):e85945.
PMID: 24465804
PMC: 3897774.
DOI: 10.1371/journal.pone.0085945.
Serum amino acid profiles and dopamine in schizophrenic patients and healthy subjects: Window to the brain?.
Rao M, Strebel B, Gross G, Huber G
Amino Acids. 2013; 2(1-2):111-8.
PMID: 24194278
DOI: 10.1007/BF00806081.
Mass spectrometry strategies for clinical metabolomics and lipidomics in psychiatry, neurology, and neuro-oncology.
Wood P
Neuropsychopharmacology. 2013; 39(1):24-33.
PMID: 23842599
PMC: 3857645.
DOI: 10.1038/npp.2013.167.
Novel nutritional treatment for manic and psychotic disorders: a review of tryptophan and tyrosine depletion studies and the potential of protein-based formulations using glycomacropeptide.
Badawy A
Psychopharmacology (Berl). 2013; 228(3):347-58.
PMID: 23828158
DOI: 10.1007/s00213-013-3191-9.
13C-phenylalanine breath test detects altered phenylalanine kinetics in schizophrenia patients.
Teraishi T, Ozeki Y, Hori H, Sasayama D, Chiba S, Yamamoto N
Transl Psychiatry. 2012; 2:e119.
PMID: 22832963
PMC: 3365267.
DOI: 10.1038/tp.2012.48.
D-amino acid oxidase activator gene (DAOA) variation affects cerebrospinal fluid homovanillic acid concentrations in healthy Caucasians.
Andreou D, Saetre P, Werge T, Andreassen O, Agartz I, Sedvall G
Eur Arch Psychiatry Clin Neurosci. 2012; 262(7):549-56.
PMID: 22454242
PMC: 3464385.
DOI: 10.1007/s00406-012-0313-z.
Recent advances in targeting the ionotropic glutamate receptors in treating schizophrenia.
McCullumsmith R, Hammond J, Funk A, Meador-Woodruff J
Curr Pharm Biotechnol. 2012; 13(8):1535-42.
PMID: 22283761
PMC: 3718462.
DOI: 10.2174/138920112800784899.
The human serum metabolome.
Psychogios N, Hau D, Peng J, Guo A, Mandal R, Bouatra S
PLoS One. 2011; 6(2):e16957.
PMID: 21359215
PMC: 3040193.
DOI: 10.1371/journal.pone.0016957.